Company Profile (AI Text)
Name: Epibone
Canonical URL: https://wefunder.com/epibone
Updated at: 2026-09-02T20:11:22Z

Tagline: Regrow your body with adult stem cells

Key claims:
- Total raised on Wefunder: 0 | citation: https://wefunder.com/epibone#claim-total-raised
- Total investors: 0 | citation: https://wefunder.com/epibone#claim-total-investors

Verified facts:
- Total raised on Wefunder: 0 | observed_at: 2026-09-02T20:11:22Z | expires_at: 2026-09-03T20:11:22Z
- Total investors: 0 | observed_at: 2026-09-02T20:11:22Z | expires_at: 2026-09-03T20:11:22Z

Computed metrics:
- total_amount_raised: 0
- total_investors: 0
- team_size: 8
- featured_investor_count: 4
- faq_count: 1
- recent_post_count: 0

Quick facts:
- First & only company with active FDA INDs for both stem cell bone & cartilage grafts | citation: https://wefunder.com/epibone#claim-fact-1
- Backed by Moderna Co-Founder Robert Langer, Peter Thiel, Henry Kravis (KKR & Co. - $700B+ AUM) | citation: https://wefunder.com/epibone#claim-fact-2
- 11+ patent families; tissue engineering science from Columbia, MIT, and Cornell | citation: https://wefunder.com/epibone#claim-fact-3
- Led by a Columbia PhD & MBA, Fulbright Scholar, ex-McKinsey, WEF Young Global Leader CEO | citation: https://wefunder.com/epibone#claim-fact-4
- 6 patients implanted. 2+ years clean follow-ups. Zero complications | citation: https://wefunder.com/epibone#claim-fact-5
- $2.5M in US Air Force contracts secured; $1.1M projected 2026 revenue | citation: https://wefunder.com/epibone#claim-fact-6
- Osteoarthritis: 595M people, $4B market, the #1 disability in civilian and military populations | citation: https://wefunder.com/epibone#claim-fact-7
- Featured in Bloomberg, CNN, CNBC, Forbes. Fast Company #6 Most Innovative Small Company In The World | citation: https://wefunder.com/epibone#claim-fact-8

FAQ:
- Q: HI, Very interesting! Can you please tell us a little about your IP Portfolio? How many granted, how many pending, and to whom are they assigned? Thank so much. Blessings
  A: Hi Kim,Thank you for the kind words and the great question! EpiBone's IP portfolio comprises 11 patent families being prosecuted internationally, covering our bioreactor platform, our cell-processing methods, and our engineered living bone and cartilage products. The portfolio is a mix of EpiBone-owned filings and foundational patents exclusively licensed to EpiBone from Columbia University, where the technology originated. A detailed schedule by jurisdiction and assignee is available in our ...